Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
29.8%
% of IDNA's 51 holdings also in CANC
31.1%
% of CANC's 46 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 4.7% | 5.6% | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.3% | 5.6% | 4.3% |
|
REVOLUTION MEDICINES, INC. | 5.6% | 3.1% | 3.1% |
|
GILEAD SCIENCES INC | 3.4% | 2.9% | 2.9% |
|
EXELIXIS INC | 4.0% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to CANC
|
SAREPTA THERAPEUTICS INC | 5.3% |
 |
SANOFI-AVENTIS | 3.9% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 3.6% |
 |
GENMAB A/S | 3.6% |
 |
ROCHE HOLDING LTD | 3.5% |
 |
BIONTECH SE SPONSORED ADR | 3.4% |
 |
BEIGENE, LTD. | 3.1% |
|
IOVANCE BIOTHERAPEUTICS INC | 3.0% |
|
MODERNA, INC. | 3.0% |
|
REVOLUTION MEDICINES, INC. | 2.4% |
IDNA Underweight Relative to CANC
|
DAIICHI SANKYO CO LTD | -4.0% |
 |
ASTRAZENECA PLC | -3.8% |
|
NOVARTIS AG | -3.7% |
|
ILLUMINA INC | -3.5% |
|
EXACT SCIENCES CORP | -3.1% |
 |
ARGENX SE ADR | -2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.7% |
|
CELLDEX THERAPEUTICS INC | -2.6% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -2.1% |